| 000 | 01705 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517160830.0 | ||
| 264 | 0 | _c20180326 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1643-3750 | ||
| 024 | 7 |
_a10.12659/msm.902324 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPang, Zhihua | |
| 245 | 0 | 0 |
_aCardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention. _h[electronic resource] |
| 260 |
_bMedical science monitor : international medical journal of experimental and clinical research _cJun 2017 |
||
| 300 |
_a2924-2930 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 |
_aCreatine Kinase, MB Form _xblood |
| 650 | 0 | 4 |
_aDiastole _xdrug effects |
| 650 | 0 | 4 | _aElective Surgical Procedures |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNicorandil _xtherapeutic use |
| 650 | 0 | 4 |
_aNo-Reflow Phenomenon _xblood |
| 650 | 0 | 4 | _aPercutaneous Coronary Intervention |
| 650 | 0 | 4 |
_aPeroxidase _xblood |
| 650 | 0 | 4 |
_aStroke Volume _xdrug effects |
| 650 | 0 | 4 |
_aSystole _xdrug effects |
| 650 | 0 | 4 |
_aTroponin I _xblood |
| 700 | 1 | _aZhao, Wei | |
| 700 | 1 | _aYao, Zhuhua | |
| 773 | 0 |
_tMedical science monitor : international medical journal of experimental and clinical research _gvol. 23 _gp. 2924-2930 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.12659/msm.902324 _zAvailable from publisher's website |
| 999 |
_c27280582 _d27280582 |
||